Literature DB >> 15149496

Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.

W H P M Vissers1, C H M Arndtz, L Muys, P E J Van Erp, E M G de Jong, P C M van de Kerkhof.   

Abstract

BACKGROUND: An influx of immunocytes, increased epidermal proliferation and abnormal keratinization are hallmarks of the psoriatic lesion. T-lymphocyte subsets in particular activated effector memory T cells and natural killer (NK) T cells have been suggested to play an important role in the pathogenesis of psoriasis.
OBJECTIVES: In the present study we investigated the number of T-cell subsets (CD4, CD8, CD45RO, CD45RA, CD2, CD25), cells expressing NK receptors (CD94 and CD161), the proliferation marker Ki67 and the keratinization marker keratin (K10) across the margin of the spreading psoriatic plaque: distant uninvolved skin, the outer margin (immediately outside the clinical edge), the inner margin (immediately inside the clinical edge) and the central area. PATIENTS AND METHODS: Eight patients with active psoriasis vulgaris participated in this study. Biopsies were taken from the spreading psoriatic lesion from the distant uninvolved skin, the outer margin, the inner margin and the central area. Biopsies were processed for immunohistochemical staining.
RESULTS: In the outer margin CD8+ (cytotoxic T cells) and CD45RO+ (memory effector T cells) T lymphocytes invade the epidermis and in this early stage the activation markers CD2 and CD25 also show a substantial increase. The next phase, from the outer to the inner margin, shows a statistically significant increase of these markers, and especially, the cells expressing NK receptors (CD94 and CD161) show a massive increase together with a significant increase of epidermal proliferation (Ki67) and a decrease of the K10+ epidermal surface.
CONCLUSIONS: CD8+, CD45RO+, CD2+ and CD25+ T cells have a role in the early phase of the psoriatic process, whereas CD94- and CD161-expressing cells together with epidermal proliferation and keratinization are involved in a later phase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149496     DOI: 10.1111/j.1365-2133.2004.05863.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  21 in total

1.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

Review 2.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

3.  Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.

Authors:  R Larsen; L P Ryder; A Svejgaard; R Gniadecki
Journal:  Clin Exp Immunol       Date:  2007-04-02       Impact factor: 4.330

4.  N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.

Authors:  Shih C Chang; Redwan Huq; Sandeep Chhabra; Christine Beeton; Michael W Pennington; Brian J Smith; Raymond S Norton
Journal:  FEBS J       Date:  2015-04-23       Impact factor: 5.542

5.  Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis.

Authors:  Woo-Jin Yun; Deok-Woo Lee; Sung-Eun Chang; Ghil-Suk Yoon; Joo-Ryung Huh; Chong-Hyun Won; Mi-Woo Lee; Sung-Eun Kim; Beom-Joon Kim; Kee-Chan Moon; Jee-Ho Choi
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

6.  Activation of keratinocyte protein kinase C zeta in psoriasis plaques.

Authors:  Yuming Zhao; Rita Fishelevich; John P Petrali; Lida Zheng; Malinina Alla Anatolievna; April Deng; Richard L Eckert; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

7.  Integrated network analysis of transcriptomic and proteomic data in psoriasis.

Authors:  Eleonora Piruzian; Sergey Bruskin; Alex Ishkin; Rustam Abdeev; Sergey Moshkovskii; Stanislav Melnik; Yuri Nikolsky; Tatiana Nikolskaya
Journal:  BMC Syst Biol       Date:  2010-04-08

8.  Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis.

Authors:  Michael D Gober; Rita Fishelevich; Yuming Zhao; Derya Unutmaz; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2007-12-13       Impact factor: 8.551

9.  Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.

Authors:  Smriti Kundu-Raychaudhuri; Yi-Je Chen; Heike Wulff; Siba P Raychaudhuri
Journal:  J Autoimmun       Date:  2014-08-28       Impact factor: 7.094

10.  Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.

Authors:  Melanie A Kleinschek; Katia Boniface; Svetlana Sadekova; Jeff Grein; Erin E Murphy; Scott P Turner; Lisa Raskin; Bela Desai; William A Faubion; Rene de Waal Malefyt; Robert H Pierce; Terrill McClanahan; Robert A Kastelein
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.